COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) A SCREENING TOOL FOR TARGET-THERAPY TREATMENT DECISION IN ELDERLY PATIENTS AFFECTED BY METASTATIC RENAL CELL CANCER (MRCC): A PROSPECTIC STUDY

被引:0
|
作者
Simonelli, C. [1 ]
Fratino, L. [1 ]
Giacalone, A. [1 ]
Sartor, I. [1 ]
Colussi, A. M. [1 ]
Lleshi, A. [1 ]
Spazzapan, S. [1 ]
Bearz, A. [1 ]
Vaccher, E. [1 ]
Tirelli, U. [1 ]
机构
[1] Natl Canc Inst, Clin Trials Off, Aviano, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:210 / 210
页数:1
相关论文
共 50 条
  • [41] A retrospective study on 73 elderly patients (≥75 years) with aggressive B-cell non Hodgkin lymphoma: Clinical significance of treatment intensity and comprehensive geriatric assessment
    Marchesi, Francesco
    Cenfra, Natalia
    Altomare, Lidia
    Dessanti, Maria L.
    Mecarocci, Sergio
    Cerchiara, Elisabetta
    Rago, Angela
    D'Andrea, Mariella
    Tomarchio, Valeria
    Olimpieri, Odoardo M.
    Tirindelli, Maria C.
    Mengarelli, Andrea
    Petti, Maria C.
    Avvisati, Guiseppe
    Cimino, Guiseppe
    JOURNAL OF GERIATRIC ONCOLOGY, 2013, 4 (03) : 242 - 248
  • [42] Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists' Group
    Hamaker, M. E.
    Seynaeve, C.
    Wymenga, A. N. M.
    van Tinteren, H.
    Nortier, J. W. R.
    Maartense, E.
    de Graaf, H.
    de Jongh, F. E.
    Braun, J. J.
    Los, M.
    Schrama, J. G.
    van Leeuwen-Stok, A. E.
    de Groot, S. M.
    Smorenburg, C. H.
    BREAST, 2014, 23 (01): : 81 - 87
  • [43] IMPACT OF A COMPREHENSIVE GERIATRIC ASSESSMENT ON MANAGEMENT STRATEGIES IN ELDERLY PATIENTS WITH ADVANCED NO SMALL CELL LUNG CANCER (NSCLC): A POLLED ANALYSIS OF TWO PHASE 2 PROSPECTIVE STUDY OF THE GFPC GROUP.
    Borget, Isabelle
    Corre, Romain
    Le Caer, Herve
    Locher, Chrystele
    Raynaud, Christine
    Decroisette, Chantal
    Berard, Henri
    Audigier-Valette, Clarisse
    Dujon, Cecile
    Auliac, Jean-Bernard
    Crequit, Jacky
    Monnet, Isabelle
    Vergnenegre, Alain
    Chouaid, Christos
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1175 - S1176
  • [44] Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study
    Corre, Romain
    Greillier, Laurent
    Le Caer, Herve
    Audigier-Valette, Clarisse
    Baize, Nathalie
    Berard, Henri
    Falchero, Lionel
    Monnet, Isabelle
    Dansin, Eric
    Vergnenegre, Alain
    Marcq, Marie
    Decroisette, Chantal
    Auliac, Jean-Bernard
    Bota, Suzanna
    Lamy, Regine
    Massuti, Bartomeu
    Dujon, Cecile
    Perol, Maurice
    Daures, Jean-Pierre
    Descourt, Renaud
    Lena, Herve
    Plassot, Carine
    Chouaid, Christos
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (13) : 1476 - +
  • [45] Treatment outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC) with sarcomatoid and/or rhabdoid (S/R) features after progressive disease (PD) on immune checkpoint therapy (ICT): The MD Anderson Cancer Center experience.
    Hahn, Andrew Warren
    Viscuse, Paul Vincent
    Surasi, Devaki Shilpa
    Bathala, Tharakeswara
    Wiele, Andrew James
    Starbuck, Michael W.
    Campbell, Matthew T.
    Shah, Amishi Yogesh
    Jonasch, Eric
    Gao, Jianjun
    Alhalabi, Omar
    Sircar, Kanishka
    Tannir, Nizar M.
    Msaouel, Pavlos
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [46] A MULTICENTER PHASE II RANDOMIZED STUDY OF GEMCITABINE(G) WEEKLY FOLLOWED BY ERLOTINIB(E) AFTER PROGRESSION VERSUS E FOLLOWED BY G AFTER PROGRESSION IN ADVANCED NON SMALL CELL LUNG CANCER(NSCLC)IN VULNERABLE ELDERLY PATIENTS SELECTED WITH A COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) (GFPC*0505)
    Jullian, Herve
    Le Caer, Herve
    Greillier, Laurent
    Corre, Romain
    Crequit, Jacky
    Falchero, Lionel
    Dujon, Celine
    Berard, Henri
    Auliac, Jean B.
    Chouaid, Christos
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1184 - S1184
  • [47] First-line Therapy Study of untreated advanced or metastatic Renal Cell Cancer A Phase III Trial of pro-active Therapy Monitoring during the Treatment with Sunitinib or Pembrolizumab in combination with Axitinib or Avelumab in Combination with Axitinib for Patients with advanced or metastatic Renal Cell Cancer (PREPARE) - AUO Study AN 49/18
    Rexer, Heidrun
    Gruenwald, Viktor
    Doehn, Christian
    AKTUELLE UROLOGIE, 2022, 53 (03) : 222 - 225
  • [48] Elderly Head and Neck Cancer (ELAN) study: Personalized treatment according to geriatric assessment in patients age 70 or older: First prospective trials in patients with squamons cell cancer of the head and neck (SCCHN) unsuitable for surgery.
    Guigay, Joel
    Le Caer, Herve
    Mertens, Cecile
    Ortholan, Cecile
    Blot, Emmanuel
    Tao, Yungan
    Peyrade, Frederic
    Polntreau, Yoann
    Guillet, Pierre
    Lafond, Cedrik
    Benezery, Karen
    Renard-Oldrini, Sophie
    Villa, Julia
    Gamier, Georges
    Alfonsi, Marc
    Lezghed, Naima
    Vintonenko, Nadejda
    Schwob, Dominique
    Capolino, Perrino
    Auperin, Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] ELAN-ONCOVAL (Elderly Head and Neck Cancer-Oncology Evaluation) study: Evaluation of the G8 screening tool and the ELAN geriatric evaluation (EGE) for elderly patients (pts) with head and neck squamous cell carcinomas (HNSCC).
    Mertens, Cecile
    Le Caer, Herve
    Ortholan, Cecile
    Blot, Emmanuel
    Even, Caroline
    Rousselot, Hubert
    Peyrade, Frederic
    Sire, Christian
    Cupissol, Didier
    Pointreau, Yoann
    Debourdeau, Philippe
    Rolland, Frederic
    Fayette, Jerome
    Capitain, Olivier
    Sun, Xu Shan
    Debbah, Moufida
    Boulahssass, Rabia
    Schwob, Dominique
    Auperin, Anne
    Guigay, Joel
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] A multicenter phase II ranomized study of gemcitabine (G) weekly followed by eriotinib (E) after progression versus E followed by G after progression in advance non-small cell lung cancer (NSCLC) in vulnerable elderly patients selected with a comprehensive geriatric assessment (CGA) (GFPC*0505)
    Jullian, H.
    Greillier, L.
    Chouaid, C.
    Corre, R.
    Crequit, J.
    Falchero, L.
    Dujon, C.
    Berard, H.
    Auliac, J. B.
    Le Caer, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)